3600 GREEN COURT, ANN ARBOR, MI
First Amendment to Merger Agreement with ASP Isotopes Inc.
Reports Second Quarter 2026 Financial Results and Provides Business Update
Other Events
Investor Presentation June 2026 CONFIDENTIAL | NOT FOR FURTHER DISTRIBUTION
Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
ENDRA Life Sciences Inc. Enters Securities Purchase Agreement for 578,387 Shares
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Financial Results, Press Release
Q1
Q3
Q2
Amended Annual Report
FY 2024
Amended Quarterly Report
S-4
Prospectus Filed Pursuant to Rule 425
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Initial Statement of Beneficial Ownership
Schedule 13D - Ownership Report
Amended Schedule 13D - Ownership Report
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload